Loading...
Bienvenue dans la collection de l'UMR 1231 - Lipides, Nutrition, Cancer
Dernières publications
-
Véronique Vendrely, Philippe Ronchin, Mathieu Minsat, Karine Le Malicot, Claire Lemanski, et al.. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial. Radiotherapy & Oncology, 2023, 186, pp.109742. ⟨10.1016/j.radonc.2023.109742⟩. ⟨hal-04163679⟩
-
-
Thomas Maldiney, Dea Garcia-Hermoso, Emilie Sitterlé, Jean-Marie Chassot, Olivier Thouvenin, et al.. Dynamic full-field optical coherence tomography for live-cell imaging and growth-phase monitoring in Aspergillus fumigatus. Frontiers in Cellular and Infection Microbiology, 2023, 13, pp.1183340. ⟨10.3389/fcimb.2023.1183340⟩. ⟨pasteur-04173133⟩
-
Véronique Vendrely, Claire Lemanski, Pascal Pommier, Karine Le Malicot, Angélique Saint, et al.. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE. Radiotherapy & Oncology, 2023, 183, pp.109542. ⟨10.1016/j.radonc.2023.109542⟩. ⟨hal-04016479⟩
-
Julie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, Marie-Sara Agier, Julien Bermudez, et al.. Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial. European Respiratory Journal, 2023, 61 (6), pp.2202071. ⟨10.1183/13993003.02071-2022⟩. ⟨hal-04113217v2⟩
Contact :
- Support HAL pour l'uB :
archives-ouvertes@u-bourgogne.fr
Quels sont vos droits ?
L’Université de Bourgogne vous informe sur l’ensemble de vos droits (diffusion de documents, politique éditeurs) en suivant ce lien
Notices1 324 |
Dépôts![]() |
Open Access
63 %
Collaborations